Stocks and Investing Stocks and Investing
Tue, December 6, 2016
[ Tue, Dec 06th 2016 ] - WOPRAI
TYPE SqueezeTrigger Price is $19.78. There is $12,625,619 That Short Sellers Still Need To Cover.
[ Tue, Dec 06th 2016 ] - WOPRAI
HCCI SqueezeTrigger Price is $14.82. There is $4,593,820 That Short Sellers Still Need To Cover.
[ Tue, Dec 06th 2016 ] - WOPRAI
CFBK SqueezeTrigger Price is $1.50. There is $51,793 That Short Sellers Still Need To Cover.
[ Tue, Dec 06th 2016 ] - WOPRAI
WRLD SqueezeTrigger Price is $60.84. There is $108,669,531 That Short Sellers Still Need To Cover.
[ Tue, Dec 06th 2016 ] - WOPRAI
TAIT SqueezeTrigger Price is $1.26. There is $27,221 That Short Sellers Still Need To Cover.
[ Tue, Dec 06th 2016 ] - WOPRAI
GTXI SqueezeTrigger Price is $3.28. There is $4,101,120 That Short Sellers Still Need To Cover.
[ Tue, Dec 06th 2016 ] - WOPRAI
CNBKA, CZNC, OLBK, MMAC, PODD, WFBI, Expected to Trade Higher After Bullish Insider Trading
[ Tue, Dec 06th 2016 ] - WOPRAI
HUBS, SHAK, SEDG, ADRO, Expected to Trade Lower After Bearish Insider Trading
[ Tue, Dec 06th 2016 ] - WOPRAI
CLNE, CIE, MXL, EVER, KITE, SFS, Expected to Trade Lower After Bearish Insider Trading
[ Tue, Dec 06th 2016 ] - WOPRAI
NUAN, ILMN, ALDR, BLCM, CUDA, FTNT, Expected to Trade Lower After Bearish Insider Trading
[ Tue, Dec 06th 2016 ] - WOPRAI
ATRS, LECO, NTGR, SAFT, VAR, GBX, Expected to Trade Lower After Bearish Insider Trading
[ Tue, Dec 06th 2016 ] - WOPRAI
OB, TFSL, AMCN, PHB, PBP, RST Are Seasonally Ripe To Go Down In the Next Five Weeks
[ Tue, Dec 06th 2016 ] - WOPRAI
PPLT, BAH Are Seasonally Ripe To Go Up In the Next Five Weeks
[ Tue, Dec 06th 2016 ] - WOPRAI
GNRC, PACB, ETE, AHGP, OKS, H Are Seasonally Ripe To Go Up In the Next Five Weeks
[ Tue, Dec 06th 2016 ] - WOPRAI
SPSC, JBK, SE, WES, MGM, KTN Are Seasonally Ripe To Go Up In the Next Five Weeks
[ Tue, Dec 06th 2016 ] - WOPRAI
NX Expected To Be Down Before Next Earnings Releases
[ Tue, Dec 06th 2016 ] - WOPRAI
MIND, CASY, COST Expected To Be Up After Next Earnings Releases
[ Tue, Dec 06th 2016 ] - WOPRAI
Matthew Keating Maintained (ASB) at Hold with Increased Target to $24 on, Dec 6th, 2016
[ Tue, Dec 06th 2016 ] - WOPRAI
Andrew Wittmann Downgraded (ABM) to Hold on, Dec 6th, 2016
[ Tue, Dec 06th 2016 ] - WOPRAI
Betsy Van Hees Initiated (AMD) at Strong Buy and Held Target at $11 on, Dec 6th, 2016
[ Tue, Dec 06th 2016 ] - WOPRAI
Brian Brungardt Maintained (AM) at Strong Buy with Increased Target to $32 on, Dec 6th, 2016
[ Tue, Dec 06th 2016 ] - WOPRAI
Brian Brungardt Upgraded (AM) to Strong Buy on, Dec 6th, 2016
[ Tue, Dec 06th 2016 ] - WOPRAI
Noelle Dilts Maintained (BDC) at Strong Buy with Decreased Target to $80 on, Dec 6th, 2016
[ Tue, Dec 06th 2016 ] - WOPRAI
Matthew Keating Upgraded (CFR) to Hold on, Dec 6th, 2016
[ Tue, Dec 06th 2016 ] - WOPRAI
Nicole Deblase Maintained (TEX) at Hold with Increased Target to $34 on, Dec 6th, 2016
[ Tue, Dec 06th 2016 ] - WOPRAI
Nishu Sood Maintained (TOL) at Strong Buy with Increased Target to $42 on, Dec 6th, 2016
[ Tue, Dec 06th 2016 ] - WOPRAI
Andrew Didora Upgraded (UAL) to Strong Buy on, Dec 6th, 2016
[ Tue, Dec 06th 2016 ] - WOPRAI
Shawn Harrison Initiated (AVGO) at Strong Buy and Held Target at $21 on, Dec 6th, 2016
[ Tue, Dec 06th 2016 ] - WOPRAI
Matthew Keating Upgraded (SNV) to Hold on, Dec 6th, 2016
[ Tue, Dec 06th 2016 ] - WOPRAI
Annabel Samimy Maintained (TXMD) at Strong Buy with Increased Target to $17 on, Dec 6th, 2016

Annabel Samimy Maintained (TXMD) at Strong Buy with Increased Target to $17 on, Dec 6th, 2016


Published on 2024-10-25 19:33:36 - WOPRAI, Annabel Samimy
  Print publication without navigation


Annabel Samimy of Stifel, Maintained "TherapeuticsMD, Inc." (TXMD) at Strong Buy with Increased Target from $14 to $17 on, Dec 6th, 2016.

Annabel has made no other calls on TXMD in the last 4 months.



There is 1 other peer that has a rating on TXMD. Out of the 1 peers that are also analyzing TXMD, 0 agree with Annabel's Rating of Hold.



This is the rating of the analyst that currently disagrees with Annabel

  • Jay Olson of "Oppenheimer" Initiated at Buy and Held Target at $12 on, Tuesday, November 22nd, 2016
Contributing Sources